HPLC Purity Standards for Research Peptides
What a purity percentage actually means in peptide testing, how HPLC measures it, and why testing conditions can affect the reported number.
Read articleWhy correct reconstitution and storage matter as much as purity, and how avoidable handling mistakes compromise research material.

A peptide can be perfectly pure on arrival and still fail in an experiment weeks later. Reconstitution and storage mistakes are one of the most common, and most avoidable, sources of bad data.
Check current availability and choose options on the product page. Research Use Only.
The way a peptide powder is reconstituted and stored determines whether the molecule remains intact for the planned experiment, and researchers quickly learned that even small lapses can render a batch useless.
Even before a peptide reaches the assay plate, physical‑chemical events can change its conformation, affecting the read‑out you intend to measure.
Peptides are chains of amino acids linked by peptide bonds; their biological activity depends on a precise three‑dimensional shape. In solution, the chain can adopt multiple conformations, and factors like pH, ionic strength, and temperature shift the equilibrium between folded and unfolded states. When a peptide unfolds, exposed side chains may interact with each other, forming aggregates that hide the functional region. Additionally, certain amino acids (for example, cysteine) can form disulfide bridges with oxygen, leading to oxidation that changes the charge distribution and interferes with binding to target receptors. By controlling the solvent composition, temperature, and exposure to light or oxygen, scientists aim to keep the peptide in its native, bio‑active conformation throughout the experiment.
Laboratories have compared peptide integrity after dissolution in pure water versus buffered saline. Chromatography and mass‑spectrometry showed that buffered solutions at physiological pH (≈7.4) reduced premature hydrolysis for many acidic peptides, while very low pH (≤2) protected basic sequences from deamidation. Researchers also observed that adding 0.1 % (w/v) bovine serum albumin lowered non‑specific adsorption to tube walls, preserving the effective concentration in cell‑based assays.
In rodent studies where peptide solutions were administered via injection, investigators stored aliquots at –80 °C versus –20 °C. After four weeks, the –80 °C samples retained over 90 % of the original purity, while the –20 °C samples showed detectable fragments on HPLC, correlating with reduced pharmacodynamic read‑outs. Similar work with lyophilised peptides reconstituted immediately before dosing demonstrated less variability in plasma concentrations compared with peptides kept in liquid form for days.
No peer‑reviewed human studies have examined the impact of reconstitution or storage conditions on research‑grade peptides, largely because human work typically requires GMP‑grade material and strict regulatory oversight. The absence of clinical data reinforces the reliance on pre‑clinical findings to guide laboratory handling.
Compared with small‑molecule drugs, peptides are inherently more sensitive to moisture, temperature, and pH because they contain numerous hydrogen‑bond donors and acceptors. Unlike many synthetic compounds that remain stable at room temperature for months, a peptide that degrades rapidly in aqueous solution can lose activity within hours if not protected. Stabilisation strategies such as lyophilisation, the use of cryoprotectants, or immediate use after reconstitution are therefore more critical for peptides than for typical organic drugs.
Key gaps remain around the exact number of freeze‑thaw cycles that begin to impact different peptide classes, the long‑term effects of low‑level oxidation on functional assays, and whether novel co‑solvents (e.g., cyclodextrin complexes) can consistently improve stability across diverse sequences. Moreover, the translation of stability data from rodent models to human‑derived cell systems is not fully characterised, leaving uncertainty about optimal handling for translational research.
All information provided is for research and educational purposes only. Peptides discussed are not listed on the Australian Register of Therapeutic Goods (ARTG) and must not be used for human or animal consumption.
Links lead to the original paper, DOI record, or open-access full text where available.
This compound is supplied for in vitro laboratory and educational research only. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Not for human or animal consumption, therapeutic use, or diagnostic procedures. By purchasing, you confirm you are a qualified researcher or acting on behalf of a licensed research facility, and you assume full responsibility for the safe handling, storage, and lawful use of this compound.
What a purity percentage actually means in peptide testing, how HPLC measures it, and why testing conditions can affect the reported number.
Read articleThe three numbers that matter most on a peptide COA — purity, mass and counter-ion content — and how to interpret them.
Read article
The general mathematics behind reconstitution ratios, presented as a concept rather than a protocol for any specific use.
Read articleA plain-language look at the regulatory context for research-use peptides in Australia and what labs should verify when sourcing compounds.
Read articleTell us what you need. An email address is required so we can reply.